about
Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesOxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammationRisk factors in coronary atherosclerosis athero-inflammation: the meeting pointAssociation between monocyte Fcgamma subclass expression and acute coronary syndromeThe human paraoxonase gene cluster as a target in the treatment of atherosclerosisInterleukin-17 and acute coronary syndromeThe bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in miceMucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J miceThe Roles of CD137 Signaling in AtherosclerosisThematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemiaIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesThe innate immune response to products of phospholipid peroxidationGeneration and biological activities of oxidized phospholipidsThe atheroprotective effect of 17beta-estradiol depends on complex interactions in adaptive immunityActin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase.Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesionsMembrane curvature recognition by C-reactive protein using lipoprotein mimics.Low levels of a natural IgM antibody are associated with vein graft stenosis and failure.Screening of a HUAEC cDNA library identifies actin as a candidate autoantigen associated with carotid atherosclerosis.Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null miceClinical significance of the humoral immune response to modified LDL.25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetesAutoantibodies and the risk of cardiovascular events.CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe⁻(/)⁻ mice.Neutrophils alter the inflammatory milieu by signal-dependent translation of constitutive messenger RNAs.The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation.Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responsesOxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics.Oxidized LDL: diversity, patterns of recognition, and pathophysiology.High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes.Emerging role of IL-17 in atherosclerosis.B cell depletion reduces the development of atherosclerosis in mice.Sensitization of human aortic endothelial cells to lipopolysaccharide via regulation of Toll-like receptor 4 by bacterial fimbria-dependent invasion.Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccineThe alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Association of response to hepatitis B vaccination and survival in dialysis patientsPlasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome.Anti-heat shock protein 70 autoantibody epitope changes and BD091 promotes atherosclerosis in rats.
P2860
Q24289511-6A42C64B-21DF-4789-A103-2D9D482AE60CQ24682128-7DD1C6BD-BE5E-48BC-BEC4-E21A923832BCQ24793107-18D46B5D-E8E7-4F0A-B99A-5E2616B602D9Q24804925-61E31E0C-4BB2-4A56-B5F1-7B33A6B1E60BQ26824356-178A60DE-8B3D-4BC5-99DF-E3D37C914E6BQ27025823-119B3A93-A5A1-47DC-992E-03F119925711Q27318414-861D48F9-48C0-4BD9-ADB9-2AC071F0CE76Q27335174-7204BF4D-683C-4C75-910E-577A183BB6F9Q28076613-BCB32BB5-A2D9-420C-B8E6-C285CCFAB7B0Q28259861-7BD93E7D-174E-41D9-B4D3-F21BF89377D9Q28388335-BF7510D8-FF6B-4E23-AF4A-F4F1DF13A6A4Q28389385-565BE247-70B4-48A1-9D91-68E3AEAFAE8EQ28389691-F827F00A-34B1-422C-91BE-64FFAB74C29CQ30478113-41F35455-6398-4D74-BF7A-CAD37699BB3EQ30480611-C2D1547C-812B-45DB-8E24-90AC5413BB68Q30488574-8051C7D1-3F33-4351-A011-472D9C78F204Q30544305-31401FAE-8FC4-46FE-B03E-3D4BEB51C002Q30547812-536CD0D4-49DD-4855-9B76-1010926A23D1Q31079034-26C066E8-0CE2-4D58-9608-1E95229F62DAQ33314514-A274A74E-9D84-4C79-9203-6038E5341FEAQ33598770-B9F4AAC7-13C7-4C3E-92BC-5B0DB3CF990DQ33632511-AB4A62C3-67BD-4677-8DE1-2A72BFCF0380Q33721605-B8AECC06-7310-4AE0-86E6-E0736BF00602Q33761718-71E7F374-0CD1-4A46-8F29-6EED97D5FB01Q33782606-2F298A89-7934-489B-B873-0C8E11B505D1Q33784558-46D278DF-9078-432C-8BB8-C02088CF701FQ33805176-DB7819BC-F631-4AFE-BC82-AEDA05ACEC28Q33819043-1567259D-01FE-45DF-958E-43CA1B84468BQ33857831-F93F7DCA-04FE-4917-85C7-21A19C49AAE4Q33879138-AD6FC948-0775-45CB-A3EE-579CF5611356Q33930928-33EE8813-63F7-49EA-B244-BED0E4A1AB3FQ33955912-E0FCBB21-1B29-4200-B97F-C10FBE1603EEQ34044387-22969926-0353-40D6-9FD7-9605B2C1A9D2Q34194509-3BAAEE36-72A6-47D3-A9D4-4E61F705F6DFQ34238712-6F5D0759-6A2E-4D01-993B-AD1083613C22Q34297184-E951D2F9-708E-4DEC-BA1F-8CD97BB8C5FBQ34350546-AE041AC5-405C-41F8-9BCD-D26BF9769DB0Q34398430-8C5C20E2-751D-44A5-BDB2-B7CF31F0800AQ34427494-6CFF6047-B143-42BD-8E94-9290E85C0794Q34505767-C608CF6A-1BD6-4157-8623-6615D78DE04D
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Innate and acquired immunity in atherogenesis.
@ast
Innate and acquired immunity in atherogenesis.
@en
Innate and acquired immunity in atherogenesis.
@nl
type
label
Innate and acquired immunity in atherogenesis.
@ast
Innate and acquired immunity in atherogenesis.
@en
Innate and acquired immunity in atherogenesis.
@nl
prefLabel
Innate and acquired immunity in atherogenesis.
@ast
Innate and acquired immunity in atherogenesis.
@en
Innate and acquired immunity in atherogenesis.
@nl
P2093
P356
P1433
P1476
Innate and acquired immunity in atherogenesis.
@en
P2093
Asheesh Dewan
Christoph J Binder
Karsten Hartvigsen
Mi-Kyung Chang
Peter X Shaw
Yury I Miller
P2888
P304
P356
10.1038/NM1102-1218
P407
P577
2002-11-01T00:00:00Z